Sharps Compliance (SMED) 10-K 23 Aug 17 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2017	Aug. 21, 2017	Dec. 31, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	SHARPS COMPLIANCE CORP
Entity Central Index Key	898,770
Current Fiscal Year End Date	--06-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Public Float			$ 48.8
Entity Common Stock, Shares Outstanding		16,008,412
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jun. 30, 2017

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016
CURRENT ASSETS
Cash and cash equivalents	$ 4,675	$ 12,435
Accounts receivable, net	7,553	5,814
Inventory, net	4,098	3,919
Prepaid and other current assets	694	695
TOTAL CURRENT ASSETS	17,020	22,863
PROPERTY, PLANT AND EQUIPMENT, net	6,543	5,032
OTHER ASSETS	120	84
GOODWILL	6,735	1,039
INTANGIBLE ASSETS, net	4,046	1,129
TOTAL ASSETS	34,464	30,147
CURRENT LIABILITIES
Accounts payable	1,710	1,620
Accrued liabilities	1,800	1,534
Current maturities of long-term debt	601	0
Deferred revenue	2,421	2,477
TOTAL CURRENT LIABILITIES	6,532	5,631
LONG-TERM DEFERRED REVENUE, net of current portion	478	483
OTHER LONG-TERM LIABILITIES	165	190
LONG-TERM DEBT, net of current portion	2,002	0
TOTAL LIABILITIES	9,177	6,304
COMMITMENTS AND CONTINGENCIES (Note 8)
STOCKHOLDERS' EQUITY
Common stock, $0.01 par value per share; 20,000,000 shares authorized; 16,304,027 and 15,740,458 shares issued, respectively and 16,008,412 and 15,444,843 shares outstanding, respectively.	163	158
Treasury stock, at cost, 295,615 shares repurchased	(1,554)	(1,554)
Additional paid-in capital	28,063	25,331
Accumulated deficit	(1,385)	(92)
TOTAL STOCKHOLDERS' EQUITY	25,287	23,843
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 34,464	$ 30,147

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2017	Jun. 30, 2016
STOCKHOLDERS' EQUITY
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	16,304,027	15,740,458
Common stock, shares outstanding (in shares)	16,008,412	15,444,843
Treasury stock, shares repurchased (in shares)	295,615	295,615

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
REVENUES	$ 38,188	$ 33,383	$ 30,902
Cost of revenues	26,351	22,272	19,907
GROSS PROFIT	11,837	11,111	10,995
Selling, general and administrative	12,223	10,812	9,496
Depreciation and amortization	801	294	263
OPERATING INCOME (LOSS)	(1,187)	5	1,236
OTHER INCOME (EXPENSE)
Interest income	13	32	36
Interest expense	(115)	0	0
TOTAL OTHER (EXPENSE) INCOME	(102)	32	36
INCOME (LOSS) BEFORE INCOME TAXES	(1,289)	37	1,272
INCOME TAX EXPENSE - Current	4	24	112
NET INCOME (LOSS)	$ (1,293)	$ 13	$ 1,160
NET INCOME (LOSS) PER COMMON SHARE
Basic (in dollars per share)	$ (0.08)	$ 0	$ 0.08
Diluted (in dollars per share)	$ (0.08)	$ 0	$ 0.07
WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME (LOSS) PER COMMON SHARE:
Basic (in shares)	15,949	15,448	15,327
Diluted (in shares)	15,949	15,838	15,564

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balances at Jun. 30, 2014	$ 155	$ (681)	$ 23,695	$ (1,265)	$ 21,904
Balances (in shares) at Jun. 30, 2014	15,460,940	(161,801)
Exercise of stock options	$ 0	$ 0	139	0	139
Exercise of stock options (in shares)	61,109	0
Stock-based compensation	$ 0	$ 0	511	0	511
Issuance of restricted stock	$ 1	$ 0	(1)	0	0
Issuance of restricted stock (in shares)	52,992	0
Shares repurchased	$ 0	$ (128)	0	0	$ (128)
Shares repurchased (in shares)	0	(29,449)			(29,449)
Net income (loss)	$ 0	$ 0	0	1,160	$ 1,160
Balances at Jun. 30, 2015	$ 156	$ (809)	24,344	(105)	23,586
Balances (in shares) at Jun. 30, 2015	15,575,041	(191,250)
Exercise of stock options	$ 1	$ 0	312	0	313
Exercise of stock options (in shares)	112,425	0
Stock-based compensation	$ 0	$ 0	676	0	676
Issuance of restricted stock	$ 1	$ 0	(1)	0	0
Issuance of restricted stock (in shares)	52,992	0
Shares repurchased	$ 0	$ (745)	0	0	$ (745)
Shares repurchased (in shares)	0	(104,365)			(104,365)
Net income (loss)	$ 0	$ 0	0	13	$ 13
Balances at Jun. 30, 2016	$ 158	$ (1,554)	25,331	(92)	$ 23,843
Balances (in shares) at Jun. 30, 2016	15,740,458	(295,615)			15,444,843
Exercise of stock options	$ 1	$ 0	341	0	$ 342
Exercise of stock options (in shares)	95,050	0
Issuance of common shares for acquisition	$ 4	$ 0	1,895	0	1,899
Issuance of common shares for acquisition (in shares)	415,527	0
Stock-based compensation	$ 0	$ 0	496	0	496
Issuance of restricted stock	$ 0	$ 0	0	0	$ 0
Issuance of restricted stock (in shares)	52,992	0
Shares repurchased (in shares)					0
Net income (loss)	$ 0	$ 0	0	(1,293)	$ (1,293)
Balances at Jun. 30, 2017	$ 163	$ (1,554)	$ 28,063	$ (1,385)	$ 25,287
Balances (in shares) at Jun. 30, 2017	16,304,027	(295,615)			16,008,412

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (1,293)	$ 13	$ 1,160
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	1,485	816	830
Loss on inventory write-down	0	17	0
Loss on disposal of property, plant and equipment	10	0	0
Stock-based compensation expense	496	676	511
Changes in operating assets and liabilities, net of effects of business acquisitions:
Restricted cash	0	0	111
Accounts receivable	(1,244)	926	(1,919)
Legal settlement receivable	0	0	1,538
Inventory	(61)	(1,055)	(1,418)
Prepaid and other assets	(35)	(46)	(259)
Accounts payable and accrued liabilities	125	(759)	1,109
Deferred revenue	(61)	600	499
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	(578)	1,188	2,162
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(2,486)	(1,926)	(727)
Cash proceeds from sale of property, plant and equipment	23	0	0
Additions to intangible assets	(163)	0	(6)
Payments for business acquisitions, net of cash acquired	(7,314)	(1,552)	0
NET CASH USED IN INVESTING ACTIVITIES	(9,940)	(3,478)	(733)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	342	313	139
Repayments of long-term debt	(3,184)	0	0
Proceeds from long-term debt	5,600	0	0
Shares repurchased	0	(745)	(128)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	2,758	(432)	11
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(7,760)	(2,722)	1,440
CASH AND CASH EQUIVALENTS, beginning of period	12,435	15,157	13,717
CASH AND CASH EQUIVALENTS, end of period	4,675	12,435	15,157
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Income taxes paid	9	152	58
Interest paid on long-term debt	107	0	0
NON-CASH INVESTING ACTIVITIES:
Issuance of common stock for acquisition	1,899	0	0
Unpaid consideration related to acquisitions	0	181	0
Transfer of equipment to inventory	118	143	0
Property, plant and equipment financed through accounts payable	$ 28	$ 0	$ 0

ORGANIZATION AND BACKGROUND

ORGANIZATION AND BACKGROUND	12 Months Ended
	Jun. 30, 2017
ORGANIZATION AND BACKGROUND [Abstract]
ORGANIZATION AND BACKGROUND	NOTE 1 - ORGANIZATION AND BACKGROUND Organization Business ® ® SM ® ® . Concentration of Customers and Service Providers . For the fiscal year ended June 30, 2017, one customer represented approximately 17% of revenues. This customer also represented approximately 10%, or $0.8 million, of the total accounts receivable balance as of June 30, 2017. For the fiscal year ended June 30, 2016, one customer represented approximately 17% of revenues and 17%, or $1.0 million, of the total accounts receivable balance as of June 30, 2016. For the fiscal year ended June 30, 2015, one customer represented approximately 17% of revenues. The Company may be adversely affected by its dependence Currently, the majority of Sharps transportation is sourced with the United States Postal Service (“USPS”), which consists of delivering the Sharps Recovery System from the end user to the Company’s facilities. The Company also has an arrangement with United Parcel Service Inc. (“UPS”) whereby UPS transports certain of the Company’s products from the end user to the Company’s facilities. Sharps maintains relationships with multiple raw materials suppliers and vendors in order to meet customer demands and assure availability of our products and solutions. With respect to the Sharps Recovery System solutions, the Company owns proprietary molds and dies and utilizes several contract manufacturers for the production of the primary raw materials. Sharps believes that alternative suitable contract manufacturers are readily available to meet the production specifications of our products and solutions. The Company utilizes national suppliers for the majority of the raw materials used in our other products and solutions and international suppliers for Pitch-It IV Poles.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Jun. 30, 2017
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Revenue Recognition The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During the fiscal years ended June 30, 2017, 2016 and 2015, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $3.4 million, $3.2 million and $2.6 million, respectively. As of June 30, 2017 and 2016, $2.7 million and $2.1 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program. Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities. Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale. Business Combinations Income Taxes The income tax provision reflects the full benefit of all positions that have been taken in the Company’s income tax returns, except to the extent that such positions are uncertain and fall below the recognition requirements. In the event that the Company determines that a tax position meets the uncertainty criteria, an additional liability or benefit will result. The amount of unrecognized tax benefit requires management to make significant assumptions about the expected outcomes of certain tax positions included in filed or yet to be filed tax returns. At June 30, 2017 and 2016, the Company did not have any uncertain tax positions. The Company is subject to income taxes in the United States and in numerous state tax jurisdictions. Tax return filings which are subject to review by federal and state tax authorities by jurisdiction are as follows: · United States – fiscal years ended June 30, 2014 and after · State of Texas – fiscal years ended June 30, 2012 and after · State of Georgia – fiscal years ended June 30, 2014 and after · State of Pennsylvania – fiscal years ended June 30, 2014 and after · Other States – fiscal years ended June 30, 2013 and after None of the Company’s federal or state tax returns are currently under examination. The Company records income tax related interest and penalties, if applicable, as a component of the provision for income tax expense. However, there were no such amounts recognized in the consolidated statements of operations in 2017, 2016 and 2015. Accounts Receivable Allowance for Doubtful Accounts Balance Beginning of Year Charges to Expense Write-offs /Payments Balance End of Year 2017 $ 63 $ 20 $ (5 ) $ 78 2016 $ 34 $ 34 $ (5 ) $ 63 2015 $ 23 $ 22 $ (11 ) $ 34 Stock-Based Compensation: Year Ended June 30, 2017 2016 2015 Stock-based compensation expense included in: Cost of revenue $ 41 $ 31 $ 22 Selling, general and administrative 455 645 489 Total $ 496 $ 676 $ 511 The Company estimates the fair value of restricted stock awards based on the closing price of the Company’s common stock on the date of the grant. The Company estimates the fair value of stock options using the Black-Scholes valuation model. Key input assumptions used to estimate the fair value of stock options include the exercise price of the award, the expected option term, the expected volatility of the Company’s stock over the option’s expected term, the risk free interest rate over the option’s expected term and the Company’s expected annual dividend yield. The risk free interest rate is derived using the U.S. Treasury yield curve in effect at date of grant. Volatility, expected life and dividend yield are based on historical experience and activity. The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Year Ended June 30, 2017 2016 2015 Weighted average risk-free interest rate 1.1 % 1.0 % 0.4 % Weighted average expected volatility 47 % 45 % 45 % Weighted average expected life (in years) 5.15 4.56 3.49 Dividend yield - - - The Company considers an estimated forfeiture rate for stock options based on historical experience and the anticipated forfeiture rates during the future contract life. Cash and Cash Equivalents Inventory Property, Plant and Equipment Computer and software development costs, which include costs of computer software developed or obtained for internal use, all programming, implementation and costs incurred with developing internal-use software, are capitalized during the development project stage. External direct costs of materials and services consumed in developing or obtaining internal-use computer software are capitalized. The Company expenses costs associated with developing or obtaining internal-use software during the preliminary project stage. Training and maintenance costs associated with system changes or internal-use software are expensed as incurred. Additionally, the costs of data cleansing, reconciliation, balancing of old data to the new system, creation of new/additional data and data conversion costs are expensed as incurred. Goodwill and Other Identifiable Intangible Assets: The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was no impairment during the years ended June 30, 2017, 2016 and 2015. Intangible Assets Shipping and Handling Fees and Costs Additional Product Related Costs Advertising Costs Research and Development Costs Realization of Long-lived Assets Employee Benefit Plans Net Income (Loss) Per Share Fair Value of Financial Instruments Fair Value Measurements · Level 1 – Quoted prices in active markets for identical assets or liabilities. · Level 2 – Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities). · Level 3 – Significant unobservable inputs (including our own assumptions in determining fair value). We use the cost, income or market valuation approaches to estimate the fair value of our assets and liabilities when insufficient market-observable data is available to support our valuation assumptions. The purchase price allocations relating to the acquisitions completed during the years ended June 30, 2017 and 2016 utilized level 3 inputs. Segment Reporting Use of Estimates Recently Issued Accounting Standards In July 2015, guidance for inventory measurement was issued, which supersedes the policy currently followed by the Company. The new guidance requires the Company to measure inventory at the lower of cost and net realizable value. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within that reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures. In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. evaluating the impact of the new guidance on its consolidated financial statements In March 2016, new guidance for stock-based compensation was issued, which simplifies the accounting for stock-based compensation related to income taxes and balance sheet and cash flow classifications. In addition, an entity can make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material In January 2017, guidance for goodwill was issued which simplifies the test for goodwill impairment. The new guidance eliminates Step 2 of the goodwill impairment test and requires a goodwill impairment to be measured as the amount by which the Company’s carrying amount exceeds its fair value, not to exceed the carrying amount of its goodwill. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2019 (effective July 1, 2020 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures; however, it may impact the impairment recognized in future periods. In September 2015, guidance for business combinations was issued, which simplifies the accounting for measurement-period adjustments. The new guidance eliminates the requirement to restate prior period financial statements for measurement period adjustments following a business combination and requires that the cumulative impact of a measurement period adjustment (including the impact on prior periods) be recognized in the reporting period in which the adjustment is identified. The provisions of the new guidance were effective for annual reporting periods beginning after December 15, 2015 (effective July 1, 2016 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2016 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures; however, it may impact the reporting of future acquisitions if and when they occur.

PROPERTY, PLANT AND EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT	12 Months Ended
	Jun. 30, 2017
PROPERTY, PLANT AND EQUIPMENT [Abstract]
PROPERTY, PLANT AND EQUIPMENT	NOTE 3 – PROPERTY, PLANT AND EQUIPMENT At June 30, 2017 and 2016, property, plant and equipment consisted of the following (in thousands): June 30, Useful Life 2017 2016 Furniture and fixtures 3 to 5 years $ 260 $ 247 Plant and equipment 3 to 17 years 7,975 6,524 Manufacturing 15 years 220 220 Computers and software 3 to 5 years 2,246 2,009 Leasehold improvements Life of Lease 2,681 964 Land 19 19 Construction-in-progress 347 1,372 13,748 11,355 Less: accumulated depreciation 7,205 6,323 Net property, plant and equipment $ 6,543 $ 5,032 Total depreciation and amortization expense in the fiscal years ended June 30, 2017, 2016 and 2015 was $0.9 million, $0.7 million and $0.8 million, respectively. Depreciation expense included in cost of revenues in the fiscal years ended 2017, 2016 and 2015 was $0.7 million, $0.5 million and $0.6 million, respectively.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Jun. 30, 2017
INCOME TAXES [Abstract]
INCOME TAXES	NOTE 4 – INCOME TAXES The components of income tax expense are as follows (in thousands): Year ended June 30, 2017 2016 2015 Current Federal $ - $ - $ 29 State 4 24 83 $ 4 $ 24 $ 112 The reconciliation of the statutory income tax rate to the Company’s effective income tax rate for the fiscal years ended June 30, 2017, 2016 and 2015 is as follows : Year Ended June 30, 2017 2016 2015 Statutory rate 34.0 % 34.0 % 34.0 % State income taxes, net (4.5 %) (18.6 %) 5.3 % Meals and entertainment (1.5 %) 38.7 % 1.2 % AMT and research and development credits 0.0 % (218.9 %) 0.0 % Other 0.2 % 1.5 % 0.0 % Effective rate before valuation allowance 28.2 % (163.3 %) 40.5 % Change in valuation allowance (28.5 %) 228.2 % (31.7 %) Effective tax rate (0.3 %) 64.9 % 8.8 % A valuation allowance has been recorded to reduce the Company’s net deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes. The establishment of valuation allowances and development of projected annual effective tax rates requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. At June 30, 2017 and 2016, the significant components of deferred tax assets and liabilities are approximated as follows (in thousands): June 30, 2017 2016 Deferred tax assets relating to: Stock compensation $ 398 $ 627 AMT and research and development credits 523 523 Deferred rent 77 82 Inventory 211 169 Professional fees 155 140 Accrued vacation 43 33 Accounts receivable allowance 49 24 Contribution carryovers 12 8 Net operating loss carryforwards 1,443 1,044 Total deferred tax assets 2,911 2,650 Deferred tax liablities related to depreciation differences (783 ) (621 ) Net deferred tax assets before valuation allowance 2,128 2,029 Valuation allowance (2,128 ) (2,029 ) Net deferred tax assets $ - $ - At June 30, 2017, the Company had net operating loss carryforwards of $4.8 million which will expire, if unused, between June 30, 2032 and June 30, 2037. At June 30, 2017, the Company had various tax credit carryforwards of $0.5 million, of which $0.3 million will expire beginning on June 30, 2030 and $0.2 million which may be carried forward indefinitely. As of June 30, 2017, the Company’s estimated net operating losses for tax return filing purposes exceeds the gross amount for financial reporting purposes by $0.6 million related to excess income tax benefits on stock-based compensation. The tax effect of this excess tax expense will be offset by the valuation allowance and have no net effect.

NOTES PAYABLE AND LONG-TERM DEB

NOTES PAYABLE AND LONG-TERM DEBT	12 Months Ended
	Jun. 30, 2017
NOTES PAYABLE AND LONG-TERM DEBT [Abstract]
NOTES PAYABLE AND LONG-TERM DEBT	NOTE 5 - NOTES PAYABLE AND LONG-TERM DEBT On March 29, 2017, the Company entered into to a credit agreement with a commercial bank (the “Credit Agreement”). The Credit Agreement, which replaced the Company’s prior credit agreement, provides for a $14.0 million credit facility, the proceeds of which may be utilized as follows: (i) $6.0 million for working capital, letters of credit (up to $2.0 million) and general corporate purposes and (ii) $8.0 million for acquisitions. Indebtedness under the Credit Agreement is secured by substantially all of the borrower’s assets with advances outstanding under the working capital portion of the credit facility at any time limited to a Borrowing Base (as defined in the Credit Agreement) equal to 80% of eligible accounts receivable plus the lessor of 50% of eligible inventory and $3 million. Advances under the acquisition portion of the credit facility are limited to 75% of the purchase price of an acquired company and convert to a five-year term note at the time of the borrowing. Borrowings bear interest at the greater of (a) zero percent or (b) the One Month ICE LIBOR plus a LIBOR Margin of 2.5%. The LIBOR Margin may increase to as high as 3.0% after September 30, 2017 depending on the Company’s cash flow leverage ratio. The interest rate as of June 30, 2017 was approximately 3.63%. The Company pays a fee of 0.25% per annum on the unused amount of the credit facility. At June 30, 2017, long-term debt consisted of the following (in thousands): Non-interest bearing, unsecured note payable assumed in acquisition (See Note 12), monthly payments of $7; maturing September 2018. $ 104 Term loan, bearing interest at 3.63%, monthly payments of $43; maturing March 2022. 2,499 Total long-term debt 2,603 Less: current portion 601 Long-term debt, net of current portion $ 2,002 The Company has availability under the Credit Agreement of $11.5 million ($6.0 million for the working capital and $5.5 million for the acquisitions) as of June 30, 2017 which may be limited by its leverage covenant. The Company also has $10,000 in letters of credit outstanding as of June 30, 2017. The Credit Agreement contains affirmative and negative covenants that, among other things, require the Company to maintain, beginning with the twelve-month period ending September 30, 2017, a maximum cash flow leverage ratio of no more than 3.5 to 1.0 and a minimum debt service coverage ratio of not less than 1.15 to 1.00. The maximum cash flow leverage ratio decreases to 3.25 to 1.0 on December 31, 2017 and to 3.0 to 1.0 on March 31, 2018. The Credit Agreement, which expires on March 29, 2019, also contains customary events of default which, if uncured, may terminate the Credit Agreement and require immediate repayment of all indebtedness to the lenders. Payments due on long-term debt during each of the five years subsequent to June 30, 2017 are as follows (in thousands): Twelve Months Ending June 30, 2018 $ 601 2019 537 2020 517 2021 517 2022 431 $ 2,603 The prior credit agreement, which was effective through March 29, 2017, provided for a $9.0 million line of credit facility with a maturity date of April 9, 2018. No amounts related to the prior credit agreement were outstanding as of June 30, 2017.

EQUITY TRANSACTIONS

EQUITY TRANSACTIONS	12 Months Ended
	Jun. 30, 2017
EQUITY TRANSACTIONS [Abstract]
EQUITY TRANSACTIONS	NOTE 6 - EQUITY TRANSACTIONS On January 7, 2013, the Company announced that its Board of Directors approved a stock repurchase program effective January 3, 2013, authorizing the Company to repurchase in the aggregate up to $3 million of its outstanding common stock over a two-year period. On March 5, 2015, the Board approved a two-year extension of the stock repurchase program through January 1, 2017. The program has not been extended. During the years ended June 30, 2017, 2016 and 2015, shares were repurchased as follows: Year Ended June 30, 2017 2016 2015 Shares repurchased - 104,365 29,449 Cash paid for shares repurchased (in thousands) $ - $ 745 $ 128 Average price paid per share $ - $ 7.14 $ 4.35 Total shares repurchased under the program are 295,615 shares at a cost of $1.6 million.

STOCK BASED COMPENSATION

STOCK BASED COMPENSATION	12 Months Ended
	Jun. 30, 2017
STOCK BASED COMPENSATION [Abstract]
STOCK BASED COMPENSATION	NOTE 7 - STOCK BASED COMPENSATION The Company sponsors the Sharps Compliance Corp. 2010 Stock Plan (the “2010 Plan”) covering employees, consultants and non-employee directors. The 2010 Stock Plan replaced the Sharps Compliance Corp. 1993 Stock Plan (the “1993 Plan”). The 2010 Plan provides for the granting of stock-based compensation (stock options or restricted stock) of up to 3,000,000 shares of the Company’s common stock of which 877,904 options and restrict ed shares are outstanding as of June 30, 2017. Options granted generally vest over a period of three to four years and expire seven The summary of activity for all restricted stock during the fiscal years ended June 30, 2017, 2016 and 2015 Year Ended June 30, 2017 2016 2015 Unvested at beginning of the year 13 13 15 Granted 53 53 53 Vested (53 ) (53 ) (55 ) Unvested at end of the year 13 13 13 The summary of activity for all stock options during the fiscal years ended June 30, 2017, 2016 and 2015 is presented in the table below (in thousands except per share amounts): Options Outstanding Weighted Average Exercise Price Options Outstanding at June 30, 2014 950 $ 4.27 Granted 516 $ 4.63 Exercised (61 ) $ 2.30 Forfeited or canceled (30 ) $ 4.68 Options Outstanding at June 30, 2015 1,375 $ 4.49 Granted 45 $ 6.62 Exercised (112 ) $ 2.77 Forfeited or canceled (18 ) $ 5.99 Options Outstanding at June 30, 2016 1,290 $ 4.69 Granted 38 $ 4.55 Exercised (95 ) $ 3.60 Forfeited or canceled (368 ) $ 5.32 Options Outstanding at June 30, 2017 865 $ 4.53 Options Exercisable at June 30, 2017 561 $ 4.39 The following table summarizes information about stock options outstanding as of June 30, 2017 (in thousands except per share amounts): Options Outstanding Range of Exercise Price Outstanding as of Weighted Average Remaining Life Weighted Average Exercise Price $ 2.51 - $3.50 41 2.49 $ 2.95 $ 3.51 - $5.50 692 3.27 $ 4.35 $ 5.51 - $7.50 132 4.82 $ 5.97 865 $ 4.53 The following table summarizes information about stock options exercisable as of June 30, 2017 (in thousands except per share amounts): Options Exercisable Range of Exercise Price Exercisable as of Weighted Average Remaining Life Weighted Average Exercise Price $ 2.51 - $3.50 39 2.46 $ 2.96 $ 3.51 - $5.50 464 2.66 $ 4.32 $ 5.51 - $7.50 58 4.78 $ 5.87 561 $ 4.39 As of June 30, 2017, there was $0.2 million of stock option and restricted stock compensation expense related to non-vested awards. This expense is expected to be recognized over a weighted average period of 1.6 years.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Jun. 30, 2017
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8 - COMMITMENTS AND CONTINGENCIES Operating Leases: Rent expense for the fiscal years ended June 30, 2017, 2016 and 2015 was $2.3 million, $1.5 million and $1.3 million, respectively. Future minimum lease payments under non-cancelable operating leases as of June 30, 2017 are as follows (in thousands): Year Ended June 30, 2018 2019 2020 2021 2022 Thereafter Operating lease obligations $ 1,812 $ 1,827 $ 1,725 $ 943 $ 274 $ 5 Performance Bonds: Other the Company is involved in legal proceedings and litigation in the ordinary course of business. In the opinion of management, the outcome of such matters will not have a material adverse effect on the Company’s consolidated financial position or consolidated results of operations.

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Jun. 30, 2017
EARNINGS PER SHARE [Abstract]
EARNINGS PER SHARE	NOTE 9 - EARNINGS PER SHARE Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares after considering the additional dilution related to common stock options and restricted stock. In computing diluted earnings per share, the outstanding common stock options are considered dilutive using the treasury stock method. The Company’s restricted stock awards are treated as outstanding for earnings per share calculations since these shares have full voting rights and are entitled to participate in dividends declared on common shares, if any, and undistributed earnings. As participating securities, the shares of restricted stock are included in the calculation of basic EPS using the two-class method. For the periods presented, the amount of earnings allocated to the participating securities was not material. The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per share amounts): Year Ended June 30, 2017 2016 2015 Net income (loss), as reported $ (1,293 ) $ 13 $ 1,160 Weighted average common shares outstanding 15,949 15,448 15,327 Effect of dilutive stock options - 390 237 Weighted average diluted common shares outstanding 15,949 15,838 15,564 Net income (loss) per common share Basic $ (0.08 ) $ 0.00 $ 0.08 Diluted $ (0.08 ) $ 0.00 $ 0.07 Employee stock options excluded from computation of diluted income per share amounts because their effect would be anti-dilutive 304 137 210

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	12 Months Ended
	Jun. 30, 2017
GOODWILL AND INTANGIBLE ASSETS [Abstract]
GOODWILL AND INTANGIBLE ASSETS	NOTE 10 – GOODWILL AND INTANGIBLE ASSETS At June 30, 2017 and June 30, 2016, intangible assets consisted of the following (in thousands): June 30, 2017 2016 Estimated Useful Lives Original Amount Accumulated Amortization Net Amount Original Amount Accumulated Amortization Net Amount Customer relationships 7 years $ 3,007 $ (490 ) $ 2,517 $ 580 $ (60 ) $ 520 Permits 6 - 15 years 1,373 (288 ) 1,085 668 (191 ) 477 Patents 5 - 17 years 383 (264 ) 119 383 (251 ) 132 Tradename 7 years 270 (39 ) 231 - - - Non-compete 5 years 117 (23 ) 94 - - - Total intangible assets, net $ 5,150 $ (1,104 ) $ 4,046 $ 1,631 $ (502 ) $ 1,129 During the years ended June 30, 2017, 2016 and 2015 amortization expense was $0.6 million, $0.1 million and $0.1 million, respectively. The changes in the carrying amount of goodwill since June 30, 2015 was as follows (in thousands): Year Ended June 30, 2017 2016 Beginning Balance $ 1,039 $ - Goodwill Acquired 5,696 1,039 Ending Balance $ 6,735 $ 1,039 As of June 30, 2017, future amortization of intangible assets is as follows (in thousands): Year Ending June 30, 2018 $ 616 2019 616 2020 616 2021 615 2022 590 Thereafter 993 $ 4,046

REVENUES BY SOLUTION

REVENUES BY SOLUTION	12 Months Ended
	Jun. 30, 2017
REVENUES BY SOLUTION [Abstract]
REVENUES BY SOLUTION	NOTE 11 – REVENUES BY SOLUTION The components of revenues by solution are as follows (dollars in thousands): Year Ended June 30, 2017 % Total 2016 % Total 2015 % Total REVENUES BY SOLUTION: Mailbacks $ 24,135 63.2 % $ 23,743 71.1 % $ 23,043 74.6 % Route-based pickup services 6,348 16.6 % 2,061 6.2 % 862 2.8 % Unused medications 3,377 8.8 % 3,531 10.6 % 2,667 8.6 % Third party treatment services 413 1.1 % 258 0.8 % 367 1.2 % Other (1) 3,915 10.3 % 3,790 11.3 % 3,963 12.8 % Total revenues $ 38,188 100.0 % $ 33,383 100.0 % $ 30,902 100.0 % (1) The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.

ACQUISITIONS

ACQUISITIONS	12 Months Ended
	Jun. 30, 2017
ACQUISITIONS [Abstract]
ACQUISITIONS	NOTE 12 – ACQUISITIONS Effective on July 17, 2015, the Company acquired Alpha Bio/Med Services LLC, a route-based pickup service located in Pennsylvania for total cash consideration of $0.7 million of which $0.1 million was withheld for payment of adjusted escrow amounts which settled in July 2016. The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 51 Fixed assets 70 Intangibles 267 Goodwill 413 Accounts payable and accrued liabilities (101 ) Total purchase price $ 700 Effective on December 14, 2015, the Company acquired Bio-Team Mobile LLC, a route-based pickup service located in Pennsylvania for total cash consideration of $1.0 million of which $0.1 million was withheld for payment of adjusted escrow amounts which settled in January 2017. The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 42 Fixed assets 68 Intangibles 313 Goodwill 626 Accounts payable and accrued liabilities (16 ) Total purchase price $ 1,033 Effective July 1, 2016, the Company acquired Citiwaste, LLC (“Citiwaste”), a route-based pickup service located in New York, which is in the business of medical, pharmaceutical and hazardous waste management primarily in the healthcare industry. The purchase price consisted of $7.0 million in cash ($3.0 million of which was borrowed under the acquisition portion of its Credit Agreement), 415,527 shares of common stock of the Company (the “Common Stock Consideration”) valued at $1.9 million, and a lease obligation paid to the seller for $0.1 million for a total consideration of $9.0 million. The issuance of the Common Stock Consideration was not registered under the Securities Act of 1933, as amended, and was issued pursuant to an exemption from the registration requirements thereunder. The Company held shares of the Common Stock Consideration in escrow for the one-year period to cover indemnification obligations of the sellers under the purchase agreement For the year ended June 30, 2017, the Company recognized approximately $3.6 million in revenues related to the operations of Citiwaste. The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Cash $ 5 Accounts receivable 495 Fixed assets 30 Intangibles 3,357 Goodwill 5,696 Accounts payable and accrued liabilities (356 ) Debt assumed (187 ) Total purchase price $ 9,040 The Company incurred acquisition related expenses for investment banking, legal and accounting fees which are included within selling, general and administrative expenses in the consolidated statements of operations as follows (in thousands): Twelve-Months Ended June 30, 2017 2016 2015 Acquisition-related expenses $ 702 $ 190 $ - The results of operations of the acquired business have been included in the consolidated statements of operations from the date of acquisition. Pro forma results of operations for Alpha Bio/Med Services and Bio-Team Mobile are not presented because the pro forma effects, individually or in the aggregate, were not material to the Company’s consolidated results of operations. The goodwill recorded for the Alpha Bio/Med Services, Bio-Team Mobile, and Citiwaste acquisitions will be deductible for income taxes. The goodwill recognized for the acquisitions since July 1, 2015 is attributable to expected revenue synergies generated by the integration of our products and services with those acquisitions, cost synergies resulting from the consolidation or elimination of certain functions, and intangible assets that do not qualify for separate recognition such as the assembled workforce of each acquisition. Supplemental Pro Forma Data (Unaudited) Citiwaste’s financial results since the date of the acquisition have been included in our consolidated financial results for the year ended June 30, 2017. The following table presents summarized unaudited pro forma financial information as if the Citiwaste acquisition occurred on July 1, 2015 (in thousands, except per-share data): Twelve-Months Ended June 30, 2016 Revenues $ 36,306 Net income (loss) $ (159 ) Weighted average common shares outstanding 15,861 Net loss per common share basic and diluted $ (0.01 ) The pro forma financial information for the period presented includes the estimated business combination accounting effects resulting from the acquisition, including primarily amortization expense of $0.5 million from the acquired intangible assets as well as interest expense as a result of debt financing used to fund the acquisition and tax effects from the pro forma adjustments.

SELECTED QUARTERLY FINANCIAL DA

SELECTED QUARTERLY FINANCIAL DATA	12 Months Ended
	Jun. 30, 2017
SELECTED QUARTERLY FINANCIAL DATA [Abstract]
SELECTED QUARTERLY FINANCIAL DATA	NOTE 13 – SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED) The following tables show quarterly financial information for the years ended June 30, 2017 and 2016. The Company believes that all necessary adjustments have been included in the amounts below to present fairly the results of such periods (in thousands expect per share amounts). Quarter Ended September 30, 2016 December 31, 2016 March 31, 2017 June 30, 2017 Total revenues $ 9,531 $ 9,707 $ 8,588 $ 10,362 Gross profit $ 2,959 $ 2,895 $ 2,352 $ 3,631 Operating income (loss) $ (940 ) $ (204 ) $ (638 ) $ 595 Net income (loss) $ (967 ) $ (227 ) $ (668 ) $ 569 Net income (loss) per share - basic and diluted $ (0.06 ) $ (0.01 ) $ (0.04 ) $ 0.04 Weighted average shares-diluted 15,868 15,929 15,994 16,029 Quarter Ended September 30, 2015 December 31, 2015 March 31, 2016 June 30, 2016 Total revenues $ 7,869 $ 9,992 $ 6,652 $ 8,870 Gross profit $ 2,879 $ 3,319 $ 1,693 $ 3,220 Operating income (loss) $ 231 $ 664 $ (1,104 ) $ 214 Net income (loss) $ 220 $ 615 $ (1,042 ) $ 220 Net income (loss) per share - basic and diluted $ 0.01 $ 0.04 $ (0.07 ) $ 0.01 Weighted average shares-diluted 15,926 16,062 15,462 15,575

SUMMARY OF SIGNIFICANT ACCOUN20

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Jun. 30, 2017
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Revenue Recognition	Revenue Recognition The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During the fiscal years ended June 30, 2017, 2016 and 2015, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $3.4 million, $3.2 million and $2.6 million, respectively. As of June 30, 2017 and 2016, $2.7 million and $2.1 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program. Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities. Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale.
Business Combinations	Business Combinations
Income Taxes	Income Taxes The income tax provision reflects the full benefit of all positions that have been taken in the Company’s income tax returns, except to the extent that such positions are uncertain and fall below the recognition requirements. In the event that the Company determines that a tax position meets the uncertainty criteria, an additional liability or benefit will result. The amount of unrecognized tax benefit requires management to make significant assumptions about the expected outcomes of certain tax positions included in filed or yet to be filed tax returns. At June 30, 2017 and 2016, the Company did not have any uncertain tax positions. The Company is subject to income taxes in the United States and in numerous state tax jurisdictions. Tax return filings which are subject to review by federal and state tax authorities by jurisdiction are as follows: · United States – fiscal years ended June 30, 2014 and after · State of Texas – fiscal years ended June 30, 2012 and after · State of Georgia – fiscal years ended June 30, 2014 and after · State of Pennsylvania – fiscal years ended June 30, 2014 and after · Other States – fiscal years ended June 30, 2013 and after None of the Company’s federal or state tax returns are currently under examination. The Company records income tax related interest and penalties, if applicable, as a component of the provision for income tax expense. However, there were no such amounts recognized in the consolidated statements of operations in 2017, 2016 and 2015.
Accounts Receivable	Accounts Receivable Allowance for Doubtful Accounts Balance Beginning of Year Charges to Expense Write-offs /Payments Balance End of Year 2017 $ 63 $ 20 $ (5 ) $ 78 2016 $ 34 $ 34 $ (5 ) $ 63 2015 $ 23 $ 22 $ (11 ) $ 34
Stock-Based Compensation	Stock-Based Compensation: Year Ended June 30, 2017 2016 2015 Stock-based compensation expense included in: Cost of revenue $ 41 $ 31 $ 22 Selling, general and administrative 455 645 489 Total $ 496 $ 676 $ 511 The Company estimates the fair value of restricted stock awards based on the closing price of the Company’s common stock on the date of the grant. The Company estimates the fair value of stock options using the Black-Scholes valuation model. Key input assumptions used to estimate the fair value of stock options include the exercise price of the award, the expected option term, the expected volatility of the Company’s stock over the option’s expected term, the risk free interest rate over the option’s expected term and the Company’s expected annual dividend yield. The risk free interest rate is derived using the U.S. Treasury yield curve in effect at date of grant. Volatility, expected life and dividend yield are based on historical experience and activity. The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Year Ended June 30, 2017 2016 2015 Weighted average risk-free interest rate 1.1 % 1.0 % 0.4 % Weighted average expected volatility 47 % 45 % 45 % Weighted average expected life (in years) 5.15 4.56 3.49 Dividend yield - - - The Company considers an estimated forfeiture rate for stock options based on historical experience and the anticipated forfeiture rates during the future contract life.
Cash and Cash Equivalents	Cash and Cash Equivalents
Inventory	Inventory
Property, Plant and Equipment	Property, Plant and Equipment Computer and software development costs, which include costs of computer software developed or obtained for internal use, all programming, implementation and costs incurred with developing internal-use software, are capitalized during the development project stage. External direct costs of materials and services consumed in developing or obtaining internal-use computer software are capitalized. The Company expenses costs associated with developing or obtaining internal-use software during the preliminary project stage. Training and maintenance costs associated with system changes or internal-use software are expensed as incurred. Additionally, the costs of data cleansing, reconciliation, balancing of old data to the new system, creation of new/additional data and data conversion costs are expensed as incurred.
Goodwill and Other Identifiable Intangible Assets	Goodwill and Other Identifiable Intangible Assets: The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was no impairment during the years ended June 30, 2017, 2016 and 2015.
Intangible Assets	Intangible Assets
Shipping and Handling Fees and Costs	Shipping and Handling Fees and Costs
Additional Product Related Costs	Additional Product Related Costs
Advertising Costs	Advertising Costs
Research and Development Costs	Research and Development Costs
Realization of Long-lived Assets	Realization of Long-lived Assets
Employee Benefit Plans	Employee Benefit Plans
Net Income (Loss) Per Share	Net Income (Loss) Per Share
Fair Value of Financial Instruments	Fair Value of Financial Instruments
Fair Value Measurements	Fair Value Measurements · Level 1 – Quoted prices in active markets for identical assets or liabilities. · Level 2 – Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities). · Level 3 – Significant unobservable inputs (including our own assumptions in determining fair value). We use the cost, income or market valuation approaches to estimate the fair value of our assets and liabilities when insufficient market-observable data is available to support our valuation assumptions. The purchase price allocations relating to the acquisitions completed during the years ended June 30, 2017 and 2016 utilized level 3 inputs.
Segment Reporting	Segment Reporting
Use of Estimates	Use of Estimates
Recently Issued Accounting Standards	Recently Issued Accounting Standards In July 2015, guidance for inventory measurement was issued, which supersedes the policy currently followed by the Company. The new guidance requires the Company to measure inventory at the lower of cost and net realizable value. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within that reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures. In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. evaluating the impact of the new guidance on its consolidated financial statements In March 2016, new guidance for stock-based compensation was issued, which simplifies the accounting for stock-based compensation related to income taxes and balance sheet and cash flow classifications. In addition, an entity can make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material In January 2017, guidance for goodwill was issued which simplifies the test for goodwill impairment. The new guidance eliminates Step 2 of the goodwill impairment test and requires a goodwill impairment to be measured as the amount by which the Company’s carrying amount exceeds its fair value, not to exceed the carrying amount of its goodwill. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2019 (effective July 1, 2020 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures; however, it may impact the impairment recognized in future periods. In September 2015, guidance for business combinations was issued, which simplifies the accounting for measurement-period adjustments. The new guidance eliminates the requirement to restate prior period financial statements for measurement period adjustments following a business combination and requires that the cumulative impact of a measurement period adjustment (including the impact on prior periods) be recognized in the reporting period in which the adjustment is identified. The provisions of the new guidance were effective for annual reporting periods beginning after December 15, 2015 (effective July 1, 2016 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2016 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures; however, it may impact the reporting of future acquisitions if and when they occur.

SUMMARY OF SIGNIFICANT ACCOUN21

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Jun. 30, 2017
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Allowance for doubtful accounts	The Company has a history of minimal uncollectible accounts. See rollforward of allowance activity below: Allowance for Doubtful Accounts Balance Beginning of Year Charges to Expense Write-offs /Payments Balance End of Year 2017 $ 63 $ 20 $ (5 ) $ 78 2016 $ 34 $ 34 $ (5 ) $ 63 2015 $ 23 $ 22 $ (11 ) $ 34
Schedule of stock-based compensation expense	Total stock-based compensation expense for the fiscal years ended June 30, 2017, 2016 and 2015 are as follows: Year Ended June 30, 2017 2016 2015 Stock-based compensation expense included in: Cost of revenue $ 41 $ 31 $ 22 Selling, general and administrative 455 645 489 Total $ 496 $ 676 $ 511
Schedule of stock option valuation assumptions	The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Year Ended June 30, 2017 2016 2015 Weighted average risk-free interest rate 1.1 % 1.0 % 0.4 % Weighted average expected volatility 47 % 45 % 45 % Weighted average expected life (in years) 5.15 4.56 3.49 Dividend yield - - -

PROPERTY, PLANT AND EQUIPMENT (

PROPERTY, PLANT AND EQUIPMENT (Tables)	12 Months Ended
	Jun. 30, 2017
PROPERTY, PLANT AND EQUIPMENT [Abstract]
Property, plant and equipment	At June 30, 2017 and 2016, property, plant and equipment consisted of the following (in thousands): June 30, Useful Life 2017 2016 Furniture and fixtures 3 to 5 years $ 260 $ 247 Plant and equipment 3 to 17 years 7,975 6,524 Manufacturing 15 years 220 220 Computers and software 3 to 5 years 2,246 2,009 Leasehold improvements Life of Lease 2,681 964 Land 19 19 Construction-in-progress 347 1,372 13,748 11,355 Less: accumulated depreciation 7,205 6,323 Net property, plant and equipment $ 6,543 $ 5,032

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Jun. 30, 2017
INCOME TAXES [Abstract]
Components of income tax expense	The components of income tax expense are as follows (in thousands): Year ended June 30, 2017 2016 2015 Current Federal $ - $ - $ 29 State 4 24 83 $ 4 $ 24 $ 112
Effective income tax rate reconciliation	The reconciliation of the statutory income tax rate to the Company’s effective income tax rate for the fiscal years ended June 30, 2017, 2016 and 2015 is as follows : Year Ended June 30, 2017 2016 2015 Statutory rate 34.0 % 34.0 % 34.0 % State income taxes, net (4.5 %) (18.6 %) 5.3 % Meals and entertainment (1.5 %) 38.7 % 1.2 % AMT and research and development credits 0.0 % (218.9 %) 0.0 % Other 0.2 % 1.5 % 0.0 % Effective rate before valuation allowance 28.2 % (163.3 %) 40.5 % Change in valuation allowance (28.5 %) 228.2 % (31.7 %) Effective tax rate (0.3 %) 64.9 % 8.8 %
Components of deferred tax assets and liabilities	At June 30, 2017 and 2016, the significant components of deferred tax assets and liabilities are approximated as follows (in thousands): June 30, 2017 2016 Deferred tax assets relating to: Stock compensation $ 398 $ 627 AMT and research and development credits 523 523 Deferred rent 77 82 Inventory 211 169 Professional fees 155 140 Accrued vacation 43 33 Accounts receivable allowance 49 24 Contribution carryovers 12 8 Net operating loss carryforwards 1,443 1,044 Total deferred tax assets 2,911 2,650 Deferred tax liablities related to depreciation differences (783 ) (621 ) Net deferred tax assets before valuation allowance 2,128 2,029 Valuation allowance (2,128 ) (2,029 ) Net deferred tax assets $ - $ -

NOTES PAYABLE AND LONG-TERM D24

NOTES PAYABLE AND LONG-TERM DEBT (Tables)	12 Months Ended
	Jun. 30, 2017
NOTES PAYABLE AND LONG-TERM DEBT [Abstract]
Schedule of long-term debt	At June 30, 2017, long-term debt consisted of the following (in thousands): Non-interest bearing, unsecured note payable assumed in acquisition (See Note 12), monthly payments of $7; maturing September 2018. $ 104 Term loan, bearing interest at 3.63%, monthly payments of $43; maturing March 2022. 2,499 Total long-term debt 2,603 Less: current portion 601 Long-term debt, net of current portion $ 2,002
Schedule of payments due on long-term debt	Payments due on long-term debt during each of the five years subsequent to June 30, 2017 are as follows (in thousands): Twelve Months Ending June 30, 2018 $ 601 2019 537 2020 517 2021 517 2022 431 $ 2,603

EQUITY TRANSACTIONS (Tables)

EQUITY TRANSACTIONS (Tables)	12 Months Ended
	Jun. 30, 2017
EQUITY TRANSACTIONS [Abstract]
Schedule of share repurchases	The program has not been extended. During the years ended June 30, 2017, 2016 and 2015, shares were repurchased as follows: Year Ended June 30, 2017 2016 2015 Shares repurchased - 104,365 29,449 Cash paid for shares repurchased (in thousands) $ - $ 745 $ 128 Average price paid per share $ - $ 7.14 $ 4.35

STOCK BASED COMPENSATION (Table

STOCK BASED COMPENSATION (Tables)	12 Months Ended
	Jun. 30, 2017
STOCK BASED COMPENSATION [Abstract]
Schedule of activity for all restricted stock	The summary of activity for all restricted stock during the fiscal years ended June 30, 2017, 2016 and 2015 Year Ended June 30, 2017 2016 2015 Unvested at beginning of the year 13 13 15 Granted 53 53 53 Vested (53 ) (53 ) (55 ) Unvested at end of the year 13 13 13
Schedule of activity for all stock options	The summary of activity for all stock options during the fiscal years ended June 30, 2017, 2016 and 2015 is presented in the table below (in thousands except per share amounts): Options Outstanding Weighted Average Exercise Price Options Outstanding at June 30, 2014 950 $ 4.27 Granted 516 $ 4.63 Exercised (61 ) $ 2.30 Forfeited or canceled (30 ) $ 4.68 Options Outstanding at June 30, 2015 1,375 $ 4.49 Granted 45 $ 6.62 Exercised (112 ) $ 2.77 Forfeited or canceled (18 ) $ 5.99 Options Outstanding at June 30, 2016 1,290 $ 4.69 Granted 38 $ 4.55 Exercised (95 ) $ 3.60 Forfeited or canceled (368 ) $ 5.32 Options Outstanding at June 30, 2017 865 $ 4.53 Options Exercisable at June 30, 2017 561 $ 4.39
Schedule of information about stock options outstanding	The following table summarizes information about stock options outstanding as of June 30, 2017 (in thousands except per share amounts): Options Outstanding Range of Exercise Price Outstanding as of Weighted Average Remaining Life Weighted Average Exercise Price $ 2.51 - $3.50 41 2.49 $ 2.95 $ 3.51 - $5.50 692 3.27 $ 4.35 $ 5.51 - $7.50 132 4.82 $ 5.97 865 $ 4.53
Schedule of information about stock options exercisable	The following table summarizes information about stock options exercisable as of June 30, 2017 (in thousands except per share amounts): Options Exercisable Range of Exercise Price Exercisable as of Weighted Average Remaining Life Weighted Average Exercise Price $ 2.51 - $3.50 39 2.46 $ 2.96 $ 3.51 - $5.50 464 2.66 $ 4.32 $ 5.51 - $7.50 58 4.78 $ 5.87 561 $ 4.39

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Jun. 30, 2017
COMMITMENTS AND CONTINGENCIES [Abstract]
Operating lease obligations	Future minimum lease payments under non-cancelable operating leases as of June 30, 2017 are as follows (in thousands): Year Ended June 30, 2018 2019 2020 2021 2022 Thereafter Operating lease obligations $ 1,812 $ 1,827 $ 1,725 $ 943 $ 274 $ 5

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Jun. 30, 2017
EARNINGS PER SHARE [Abstract]
Earnings per share	The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per share amounts): Year Ended June 30, 2017 2016 2015 Net income (loss), as reported $ (1,293 ) $ 13 $ 1,160 Weighted average common shares outstanding 15,949 15,448 15,327 Effect of dilutive stock options - 390 237 Weighted average diluted common shares outstanding 15,949 15,838 15,564 Net income (loss) per common share Basic $ (0.08 ) $ 0.00 $ 0.08 Diluted $ (0.08 ) $ 0.00 $ 0.07 Employee stock options excluded from computation of diluted income per share amounts because their effect would be anti-dilutive 304 137 210

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	12 Months Ended
	Jun. 30, 2017
GOODWILL AND INTANGIBLE ASSETS [Abstract]
Schedule of intangible assets	At June 30, 2017 and June 30, 2016, intangible assets consisted of the following (in thousands): June 30, 2017 2016 Estimated Useful Lives Original Amount Accumulated Amortization Net Amount Original Amount Accumulated Amortization Net Amount Customer relationships 7 years $ 3,007 $ (490 ) $ 2,517 $ 580 $ (60 ) $ 520 Permits 6 - 15 years 1,373 (288 ) 1,085 668 (191 ) 477 Patents 5 - 17 years 383 (264 ) 119 383 (251 ) 132 Tradename 7 years 270 (39 ) 231 - - - Non-compete 5 years 117 (23 ) 94 - - - Total intangible assets, net $ 5,150 $ (1,104 ) $ 4,046 $ 1,631 $ (502 ) $ 1,129
Schedule of goodwill	The changes in the carrying amount of goodwill since June 30, 2015 was as follows (in thousands): Year Ended June 30, 2017 2016 Beginning Balance $ 1,039 $ - Goodwill Acquired 5,696 1,039 Ending Balance $ 6,735 $ 1,039
Schedule of future amortization of intangible assets	As of June 30, 2017, future amortization of intangible assets is as follows (in thousands): Year Ending June 30, 2018 $ 616 2019 616 2020 616 2021 615 2022 590 Thereafter 993 $ 4,046

REVENUES BY SOLUTION (Tables)

REVENUES BY SOLUTION (Tables)	12 Months Ended
	Jun. 30, 2017
REVENUES BY SOLUTION [Abstract]
Schedule of billings by solution	The components of revenues by solution are as follows (dollars in thousands): Year Ended June 30, 2017 % Total 2016 % Total 2015 % Total REVENUES BY SOLUTION: Mailbacks $ 24,135 63.2 % $ 23,743 71.1 % $ 23,043 74.6 % Route-based pickup services 6,348 16.6 % 2,061 6.2 % 862 2.8 % Unused medications 3,377 8.8 % 3,531 10.6 % 2,667 8.6 % Third party treatment services 413 1.1 % 258 0.8 % 367 1.2 % Other (1) 3,915 10.3 % 3,790 11.3 % 3,963 12.8 % Total revenues $ 38,188 100.0 % $ 33,383 100.0 % $ 30,902 100.0 % (1) The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.

ACQUISITIONS (Tables)

ACQUISITIONS (Tables)	12 Months Ended
	Jun. 30, 2017
Business Acquisition [Line Items]
Summary of acquisition related costs	The Company incurred acquisition related expenses for investment banking, legal and accounting fees which are included within selling, general and administrative expenses in the consolidated statements of operations as follows (in thousands): Twelve-Months Ended June 30, 2017 2016 2015 Acquisition-related expenses $ 702 $ 190 $ -
Summary of unaudited pro forma financial information	The following table presents summarized unaudited pro forma financial information as if the Citiwaste acquisition occurred on July 1, 2015 (in thousands, except per-share data): Twelve-Months Ended June 30, 2016 Revenues $ 36,306 Net income (loss) $ (159 ) Weighted average common shares outstanding 15,861 Net loss per common share basic and diluted $ (0.01 )
Alpha Bio/Med Services LLC [Member]
Business Acquisition [Line Items]
Preliminary purchase price allocation	The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 51 Fixed assets 70 Intangibles 267 Goodwill 413 Accounts payable and accrued liabilities (101 ) Total purchase price $ 700
Bio-Team Mobile LLC [Member]
Business Acquisition [Line Items]
Preliminary purchase price allocation	The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Accounts receivable $ 42 Fixed assets 68 Intangibles 313 Goodwill 626 Accounts payable and accrued liabilities (16 ) Total purchase price $ 1,033
Citiwaste LLC [Member]
Business Acquisition [Line Items]
Preliminary purchase price allocation	The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands): Cash $ 5 Accounts receivable 495 Fixed assets 30 Intangibles 3,357 Goodwill 5,696 Accounts payable and accrued liabilities (356 ) Debt assumed (187 ) Total purchase price $ 9,040

SELECTED QUARTERLY FINANCIAL 32

SELECTED QUARTERLY FINANCIAL DATA (Tables)	12 Months Ended
	Jun. 30, 2017
SELECTED QUARTERLY FINANCIAL DATA [Abstract]
Schedule of quarterly financial information	The following tables show quarterly financial information for the years ended June 30, 2017 and 2016. The Company believes that all necessary adjustments have been included in the amounts below to present fairly the results of such periods (in thousands expect per share amounts). Quarter Ended September 30, 2016 December 31, 2016 March 31, 2017 June 30, 2017 Total revenues $ 9,531 $ 9,707 $ 8,588 $ 10,362 Gross profit $ 2,959 $ 2,895 $ 2,352 $ 3,631 Operating income (loss) $ (940 ) $ (204 ) $ (638 ) $ 595 Net income (loss) $ (967 ) $ (227 ) $ (668 ) $ 569 Net income (loss) per share - basic and diluted $ (0.06 ) $ (0.01 ) $ (0.04 ) $ 0.04 Weighted average shares-diluted 15,868 15,929 15,994 16,029 Quarter Ended September 30, 2015 December 31, 2015 March 31, 2016 June 30, 2016 Total revenues $ 7,869 $ 9,992 $ 6,652 $ 8,870 Gross profit $ 2,879 $ 3,319 $ 1,693 $ 3,220 Operating income (loss) $ 231 $ 664 $ (1,104 ) $ 214 Net income (loss) $ 220 $ 615 $ (1,042 ) $ 220 Net income (loss) per share - basic and diluted $ 0.01 $ 0.04 $ (0.07 ) $ 0.01 Weighted average shares-diluted 15,926 16,062 15,462 15,575

ORGANIZATION AND BACKGROUND (De

ORGANIZATION AND BACKGROUND (Details) $ in Thousands	12 Months Ended
	Jun. 30, 2017USD ($)StateRegionCustomer	Jun. 30, 2016USD ($)Customer	Jun. 30, 2015Customer
Concentration Risk [Line Items]
Number of route-based pick-up service in state region | StateRegion	23
Concentration risk, percentage	100.00%	100.00%	100.00%
Accounts receivable | $	$ 7,553	$ 5,814
Customer Concentration Risk [Member] | Sales Revenue, Services, Net [Member]
Concentration Risk [Line Items]
Number of customers | Customer	1	1	1
Concentration risk, percentage	17.00%	17.00%	17.00%
Credit Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk [Line Items]
Number of customers | Customer	1	1
Concentration risk, percentage	10.00%	17.00%
Accounts receivable | $	$ 800	$ 1,000

SUMMARY OF SIGNIFICANT ACCOUN34

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Revenue Recognition (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Revenue Recognition [Abstract]
Revenue recorded from bill and hold inventory	$ 3.4	$ 3.2	$ 2.6
Bill and hold inventory	$ 2.7	$ 2.1

SUMMARY OF SIGNIFICANT ACCOUN35

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Income Taxes [Abstract]
Liability for uncertain tax positions	$ 0	$ 0
Internal Revenue Service (IRS) [Member] | Minimum [Member]
Income Tax Contingency [Line Items]
Open tax years	2,014
State of Texas [Member] | Minimum [Member]
Income Tax Contingency [Line Items]
Open tax years	2,012
State of Georgia [Member] | Minimum [Member]
Income Tax Contingency [Line Items]
Open tax years	2,014
States of Pennsylvania [Member] | Minimum [Member]
Income Tax Contingency [Line Items]
Open tax years	2,014
Other States [Member] | Minimum [Member]
Income Tax Contingency [Line Items]
Open tax years	2,013

SUMMARY OF SIGNIFICANT ACCOUN36

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Accounts Receivable (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Allowance for Doubtful Accounts [Roll Forward]
Balance beginning of year	$ 63	$ 34	$ 23
Charges to expense	20	34	22
Write-offs /payments	(5)	(5)	(11)
Balance end of year	$ 78	$ 63	$ 34

SUMMARY OF SIGNIFICANT ACCOUN37

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Stock-Based Compensation (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 496	$ 676	$ 511
Valuation assumptions [Abstract]
Weighted average risk-free interest rate	1.10%	1.00%	0.40%
Weighted average expected volatility	47.00%	45.00%	45.00%
Weighted average expected life	5 years 1 month 24 days	4 years 6 months 22 days	3 years 5 months 26 days
Dividend yield	0.00%	0.00%	0.00%
Cost of Revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 41	$ 31	$ 22
Selling, General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 455	$ 645	$ 489

SUMMARY OF SIGNIFICANT ACCOUN38

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Cash and Cash Equivalents and Inventory (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Inventory [Abstract]
Total inventory	$ 4,098	$ 3,919
Finished goods	2,800	2,500
Raw materials	1,300	1,400
Loss on inventory write-down	0	17	$ 0
Goodwill and Other Identifiable Intangible Assets
Goodwill impairment loss	$ 0	$ 0	$ 0

SUMMARY OF SIGNIFICANT ACCOUN39

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Intangible Assets (Details) - Patent	1 Months Ended									12 Months Ended
	Jan. 30, 2014	Nov. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Aug. 31, 2012	Apr. 30, 2012	Jan. 31, 2012	Nov. 30, 2003	Jun. 30, 1998	Jun. 30, 2017
Intangible Assets [Abstract]
Intangible assets description										Intangible assets consist of (i) acquired customer relationships, (ii) permit costs related to the Company’s treatment facility in Carthage, Texas, and (iii) eleven patents (two acquired in June 1998, one in November 2003, one in January 2012, two in April 2012, one in August 2012, one in September 2012, one in December 2012, one in November 2013 and one in January 2014), and (iv) defense costs related to certain existing patents.
Number of patents acquired	1	1	1	1	1	2	1	1	2	11

SUMMARY OF SIGNIFICANT ACCOUN40

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Advertising Costs, Research, Development Costs and Realization of Long-lived Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Advertising Costs [Abstract]
Advertising costs	$ 0.8	$ 0.6	$ 0.6
Realization of Long-lived Assets [Abstract]
Impairment losses recognized	0	0	0
Maximum [Member]
Research and Development Expenses [Line Items]
Research and development expenses	$ 0.1	$ 0.1	$ 0.1

SUMMARY OF SIGNIFICANT ACCOUN41

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Employee Benefit Plans (Details) - USD ($)	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Defined Contribution Plan Disclosure [Line Items]
Employers match percentage	25.00%
Maximum annual percentage contribution per employee	6.00%
Prior group health benefit plan, individual deductible	$ 2,500
Group health benefit plan, family deductible	2,500
Group health benefit plan, third party insurance company coverage beginning amount, individual	2,500
Group health benefit plan, third party insurance company coverage beginning amount, family	10,000
Maximum [Member]
Defined Contribution Plan Disclosure [Line Items]
Company contributions to the 401(k) plan	100,000	$ 100,000	$ 100,000
Self-insured liability, health insurance	100,000	100,000
Executives [Member]
Defined Contribution Plan Disclosure [Line Items]
Aggregate stock-based compensation expense	$ 0	$ 0	$ 300,000

PROPERTY, PLANT AND EQUIPMENT42

PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 13,748	$ 11,355
Less: accumulated depreciation	7,205	6,323
Net property, plant and equipment	6,543	5,032
Depreciation and amortization expense	900	700	$ 800
Depreciation expense included in cost of revenues	700	500	$ 600
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 260	247
Furniture and Fixtures [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful life	3 years
Furniture and Fixtures [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful life	5 years
Plant and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 7,975	6,524
Plant and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful life	3 years
Plant and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful life	17 years
Manufacturing [Member]
Property, Plant and Equipment [Line Items]
Useful life	15 years
Gross property, plant and equipment	$ 220	220
Computers and Software [Member]
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 2,246	2,009
Computers and Software [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful life	3 years
Computers and Software [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful life	5 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 2,681	964
Land [Member]
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	19	19
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 347	$ 1,372

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Current [Abstract]
Federal	$ 0	$ 0	$ 29
State	4	24	83
Current income tax expense, total	$ 4	$ 24	$ 112
Effective income tax rate reconciliation [Abstract]
Statutory rate	34.00%	34.00%	34.00%
State income taxes, net	(4.50%)	(18.60%)	5.30%
Meals and entertainment	(1.50%)	38.70%	1.20%
AMT and research and development credits	0.00%	(218.90%)	0.00%
Other	0.20%	1.50%	0.00%
Effective rate before valuation allowance	28.20%	(163.30%)	40.50%
Change in valuation allowance	(28.50%)	228.20%	(31.70%)
Effective tax rate	(0.30%)	64.90%	8.80%
Deferred tax assets relating to [Abstract]
Stock compensation	$ 398	$ 627
AMT and research and development credits	523	523
Deferred rent	77	82
Inventory	211	169
Professional fees	155	140
Accrued vacation	43	33
Accounts receivable allowance	49	24
Contribution carryovers	12	8
Net operating loss carryforwards	1,443	1,044
Total deferred tax assets	2,911	2,650
Deferred tax liabilities related to depreciation differences	(783)	(621)
Net deferred tax assets before valuation allowance	2,128	2,029
Valuation allowance	(2,128)	(2,029)
Net deferred tax assets	0	$ 0
Tax Credit Carryforward [Line Items]
Net operating loss carryforwards	4,800
Tax credit carryforward, amount	500
Tax credit carryforward, amount expiration indefinitely	$ 200
Tax credit carryforward, expiration date	indefinitely
Estimated net operating losses for tax return exceeds the gross amount	$ 600
Minimum [Member]
Tax Credit Carryforward [Line Items]
Operating loss carryforwards, expiration dates	Jun. 30, 2032
Maximum [Member]
Tax Credit Carryforward [Line Items]
Operating loss carryforwards, expiration dates	Jun. 30, 2037
2030 [Member]
Tax Credit Carryforward [Line Items]
Tax credit carryforward, amount	$ 300
Tax credit carryforward, expiration date	Jun. 30, 2030

NOTES PAYABLE AND LONG-TERM D44

NOTES PAYABLE AND LONG-TERM DEBT (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016	Jun. 30, 2016
Long-term debt [Abstract]
Total long-term debt	$ 2,603
Less: current portion	601		$ 0
Long-term debt, net of current portion	2,002		$ 0
Unsecured Note Payable [Member]
Long-term debt [Abstract]
Monthly payments	$ 7
Maturity date	Sep. 30, 2018
Total long-term debt	$ 104
Term Loan [Member]
Line of Credit Facility [Line Items]
Maturity period	5 years
Interest rate	3.63%
Long-term debt [Abstract]
Monthly payments	$ 43
Maturity date	Mar. 31, 2022
Total long-term debt	$ 2,499
Credit Agreement [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 14,000
Percentage of eligible accounts receivable considered for borrowing base	80.00%
Percentage of eligible inventory considered for borrowing base	50.00%
Amount of convenant for borrowing base	$ 3,000
Unused capacity, commitment fee percentage	0.25%
Remaining borrowing capacity	$ 11,500
Basis spread of variable rate	0.00%
Credit Agreement [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Debt service coverage ratio	1.15
Credit Agreement [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Debt cash flow leverage ratio	3.5
Debt cash flow of leverage ratio as on December 31, 2017	3.25
Decrease in cash flow of leverage ratio as on March 31, 2018	3
Credit Agreement [Member] | LIBOR [Member]
Line of Credit Facility [Line Items]
Debt instrument, term of variable rate	1 month
Basis spread of variable rate	2.50%
Credit Agreement [Member] | LIBOR [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Basis spread of variable rate	3.00%
Credit Agreement [Member] | Working Capital [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 6,000
Remaining borrowing capacity	6,000
Credit Agreement [Member] | Letters of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	2,000
Amount outstanding	10
Credit Agreement [Member] | Acquisitions [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 8,000
Percentage of portion allocated to acquisition purchase price	75.00%
Remaining borrowing capacity	$ 5,500
Prior Credit Agreement [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 9,000
Line of credit facility outstanding		$ 0
Long-term debt [Abstract]
Maturity date	Apr. 9, 2018

NOTES PAYABLE AND LONG-TERM D45

NOTES PAYABLE AND LONG-TERM DEBT, Payments Due on Long-term Debt (Details) $ in Thousands	Jun. 30, 2017USD ($)
Payments due on long-term debt [Abstract]
2,018	$ 601
2,019	537
2,020	517
2,021	517
2,022	431
Total long-term debt	$ 2,603

EQUITY TRANSACTIONS (Details)

EQUITY TRANSACTIONS (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015	Jan. 07, 2013
EQUITY TRANSACTIONS [Abstract]
Stock repurchase program, authorized amount				$ 3,000
Stock repurchase program, period	2 years
Stock repurchase program term extension	2 years
Shares repurchased [Abstract]
Shares repurchased (in shares)	0	104,365	29,449
Cash paid for shares repurchased	$ 0	$ 745	$ 128
Average price paid per share (in dollars per share)	$ 0	$ 7.14	$ 4.35
Total shares repurchased under the program (in shares)	295,615	295,615
Total shares repurchased under the program, at cost	$ 1,554	$ 1,554

STOCK BASED COMPENSATION (Detai

STOCK BASED COMPENSATION (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Non-vested award [Abstract]
Expense for non-vested awards	$ 200
Weighted average period for expense recognition	1 year 7 months 6 days
Stock Options [Member]
Stock Option Activity [Rollforward]
Options outstanding at beginning of period (in shares)	1,290,000	1,375,000	950,000
Granted (in shares)	38,000	45,000	516,000
Exercised (in shares)	(95,000)	(112,000)	(61,000)
Forfeited or canceled (in shares)	(368,000)	(18,000)	(30,000)
Options outstanding at end of period (in shares)	865,000	1,290,000	1,375,000
Options exercisable (in shares)	561,000
Weighted Average Exercise Price [Abstract]
Options outstanding at beginning of period (in dollars per share)	$ 4.69	$ 4.49	$ 4.27
Granted (in dollars per share)	4.55	6.62	4.63
Exercised (in dollars per share)	3.60	2.77	2.30
Forfeited or canceled (in dollars per share)	5.32	5.99	4.68
Options outstanding at end of period (in dollars per share)	4.53	$ 4.69	$ 4.49
Options exercisable (in dollars per share)	$ 4.39
Restricted Stock [Member]
Restricted stock activity [Rollforward]
Unvested at beginning of the year (in shares)	13,000	13,000	15,000
Granted (in shares)	53,000	53,000	53,000
Vested (in shares)	(53,000)	(53,000)	(55,000)
Unvested at end of the year (in shares)	13,000	13,000	13,000
Weighted Average Fair Value [Abstract]
Grants (in dollars per share)	$ 4.38	$ 8	$ 4.28
Vested (in dollars per share)	$ 5.29	$ 7.07	$ 4.44
2010 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common shares authorized (in shares)	3,000,000
Shares outstanding (in shares)	877,904
Options available for grant (in shares)	1,561,891
2010 Stock Plan [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period	7 years
2010 Stock Plan [Member] | Stock Options [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
2010 Stock Plan [Member] | Stock Options [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years
2010 Stock Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
1993 Stock Plan [Member] | Stock Options [Member]
Stock Option Activity [Rollforward]
Options outstanding at end of period (in shares)	0

STOCK BASED COMPENSATION, Stock

STOCK BASED COMPENSATION, Stock options exercisable (Details) shares in Thousands	12 Months Ended
	Jun. 30, 2017$ / sharesshares
Options Outstanding [Abstract]
Outstanding (in shares) | shares	865
Weighted average exercise price (in dollars per share)	$ 4.53
Options Exercisable [Abstract]
Exercisable (in shares) | shares	561
Weighted average exercise price (in dollars per share)	$ 4.39
$2.51-$3.50 [Member]
Options Outstanding [Abstract]
Range of exercise price, minimum (in dollars per share)	2.51
Range of exercise price, maximum (in dollars per share)	$ 3.50
Outstanding (in shares) | shares	41
Weighted average remaining life	2 years 5 months 26 days
Weighted average exercise price (in dollars per share)	$ 2.95
Options Exercisable [Abstract]
Exercisable (in shares) | shares	39
Weighted average remaining life	2 years 5 months 16 days
Weighted average exercise price (in dollars per share)	$ 2.96
$3.51-$5.50 [Member]
Options Outstanding [Abstract]
Range of exercise price, minimum (in dollars per share)	3.51
Range of exercise price, maximum (in dollars per share)	$ 5.50
Outstanding (in shares) | shares	692
Weighted average remaining life	3 years 3 months 7 days
Weighted average exercise price (in dollars per share)	$ 4.35
Options Exercisable [Abstract]
Exercisable (in shares) | shares	464
Weighted average remaining life	2 years 7 months 28 days
Weighted average exercise price (in dollars per share)	$ 4.32
$5.51-$7.50 [Member]
Options Outstanding [Abstract]
Range of exercise price, minimum (in dollars per share)	5.51
Range of exercise price, maximum (in dollars per share)	$ 7.50
Outstanding (in shares) | shares	132
Weighted average remaining life	4 years 9 months 25 days
Weighted average exercise price (in dollars per share)	$ 5.97
Options Exercisable [Abstract]
Exercisable (in shares) | shares	58
Weighted average remaining life	4 years 9 months 11 days
Weighted average exercise price (in dollars per share)	$ 5.87

COMMITMENTS AND CONTINGENCIES49

COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands	12 Months Ended
	Jun. 30, 2017USD ($)Facility	Jun. 30, 2016USD ($)	Jun. 30, 2015USD ($)
Operating Leases [Line Items]
Number of fully-permitted facility | Facility	2
Rent expense	$ 2,300	$ 1,500	$ 1,300
Future minimum lease payments [Abstract]
2,018	1,812
2,019	1,827
2,020	1,725
2,021	943
2,022	274
Thereafter	5
Maximum [Member]
Future minimum lease payments [Abstract]
Performance bonds outstanding covering financial assurance	$ 600
U.S [Member] | Minimum [Member]
Operating Leases [Line Items]
Option to renew lease, term	3 years
U.S [Member] | Maximum [Member]
Operating Leases [Line Items]
Option to renew lease, term	10 years

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
EARNINGS PER SHARE [Abstract]
Net (income) loss, as reported	$ 569	$ (668)	$ (227)	$ (967)	$ 220	$ (1,042)	$ 615	$ 220	$ (1,293)	$ 13	$ 1,160
Weighted average common shares outstanding (in shares)									15,949	15,448	15,327
Effect of dilutive stock options (in shares)									0	390	237
Weighted average diluted common shares outstanding (in shares)	16,029	15,994	15,929	15,868	15,575	15,462	16,062	15,926	15,949	15,838	15,564
Net income (loss) per common share [Abstract]
Basic (in dollars per share)									$ (0.08)	$ 0	$ 0.08
Diluted (in dollars per share)									$ (0.08)	$ 0	$ 0.07
Employee stock options excluded from computation of diluted income per share amounts because their effect would be anti-dilutive (in shares)									304	137	210

GOODWILL AND INTANGIBLE ASSET51

GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Finite-Lived Intangible Assets [Line Items]
Intangible assets, original amount	$ 5,150	$ 1,631
Intangible assets, accumulated amortization	(1,104)	(502)
Total	4,046	1,129
Intangible assets, amortization expense	600	100	$ 100
Goodwill [Roll Forward]
Beginning Balance	1,039	0
Goodwill Acquired	5,696	1,039
Ending Balance	6,735	1,039	$ 0
Future amortization of intangible assets [Abstract]
2,018	616
2,019	616
2,020	616
2,021	615
2,022	590
Thereafter	993
Total	$ 4,046	1,129
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	7 years
Intangible assets, original amount	$ 3,007	580
Intangible assets, accumulated amortization	(490)	(60)
Total	2,517	520
Future amortization of intangible assets [Abstract]
Total	2,517	520
Permits [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, original amount	1,373	668
Intangible assets, accumulated amortization	(288)	(191)
Total	1,085	477
Future amortization of intangible assets [Abstract]
Total	$ 1,085	477
Permits [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	6 years
Permits [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	15 years
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, original amount	$ 383	383
Intangible assets, accumulated amortization	(264)	(251)
Total	119	132
Future amortization of intangible assets [Abstract]
Total	$ 119	132
Patents [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	5 years
Patents [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	17 years
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	7 years
Intangible assets, original amount	$ 270	0
Intangible assets, accumulated amortization	(39)	0
Total	231	0
Future amortization of intangible assets [Abstract]
Total	$ 231	0
Non-compete [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	5 years
Intangible assets, original amount	$ 117	0
Intangible assets, accumulated amortization	(23)	0
Total	94	0
Future amortization of intangible assets [Abstract]
Total	$ 94	$ 0

REVENUES BY SOLUTION (Details)

REVENUES BY SOLUTION (Details) - USD ($) $ in Thousands		3 Months Ended								12 Months Ended
		Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Segment Reporting Information [Line Items]
Total revenues		$ 10,362	$ 8,588	$ 9,707	$ 9,531	$ 8,870	$ 6,652	$ 9,992	$ 7,869	$ 38,188	$ 33,383	$ 30,902
Revenue percentage										100.00%	100.00%	100.00%
Mailbacks [Member]
Segment Reporting Information [Line Items]
Total revenues										$ 24,135	$ 23,743	$ 23,043
Revenue percentage										63.20%	71.10%	74.60%
Route-based Pickup Services [Member]
Segment Reporting Information [Line Items]
Total revenues										$ 6,348	$ 2,061	$ 862
Revenue percentage										16.60%	6.20%	2.80%
Unused Medications [Member]
Segment Reporting Information [Line Items]
Total revenues										$ 3,377	$ 3,531	$ 2,667
Revenue percentage										8.80%	10.60%	8.60%
Third Party Treatment Services [Member]
Segment Reporting Information [Line Items]
Total revenues										$ 413	$ 258	$ 367
Revenue percentage										1.10%	0.80%	1.20%
Other [Member]
Segment Reporting Information [Line Items]
Total revenues	[1]									$ 3,915	$ 3,790	$ 3,963
Revenue percentage	[1]									10.30%	11.30%	12.80%
[1]	The Company's other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.

ACQUISITIONS (Details)

ACQUISITIONS (Details) - USD ($) $ / shares in Units, $ in Thousands	Jul. 02, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015	Dec. 14, 2015	Jul. 17, 2015
Preliminary purchase price allocation [Abstract]
Goodwill		$ 6,735	$ 1,039	$ 0
Business acquisition related expenses [Abstract]
Acquisition related expenses		702	190	0
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Amortization expense from acquired intangible assets		600	100	$ 100
Acquisition-related Costs [Member]
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Amortization expense from acquired intangible assets		$ 500
Alpha Bio/Med Services LLC [Member]
Preliminary purchase price allocation [Abstract]
Accounts receivable						$ 51
Fixed assets						70
Intangibles						267
Goodwill						413
Accounts payable and accrued liabilities						(101)
Total purchase price						700
Cash consideration withheld for possible settlement amounts						$ 100
Bio-Team Mobile LLC [Member]
Preliminary purchase price allocation [Abstract]
Accounts receivable					$ 42
Fixed assets					68
Intangibles					313
Goodwill					626
Accounts payable and accrued liabilities					(16)
Total purchase price					1,033
Cash consideration withheld for possible settlement amounts					$ 100
Citiwaste LLC [Member]
Preliminary purchase price allocation [Abstract]
Cash	$ 5
Accounts receivable	495
Fixed assets	30
Intangibles	3,357
Goodwill	5,696
Accounts payable and accrued liabilities	(356)
Debt assumed	(187)
Total purchase price	9,040
Purchase price of acquisition	$ 7,000
Number of shares for purchase price of acquisition (in shares)	415,527
Purchase price of acquisition value	$ 1,900
Lease obligation amount	100
Total consideration amount	9,000
Escrow period for common stock consideration		1 year
Revenues		$ 3,600
Supplemental pro forma data [Abstract]
Revenues			36,306
Net income (loss)			$ (159)
Weighted average common shares outstanding (in shares)			15,861,000
Net loss per common share basic and diluted (in dollars per share)			$ (0.01)
Citiwaste LLC [Member] | Credit Agreement [Member]
Preliminary purchase price allocation [Abstract]
Amount outstanding	$ 3,000

SELECTED QUARTERLY FINANCIAL 54

SELECTED QUARTERLY FINANCIAL DATA (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
SELECTED QUARTERLY FINANCIAL DATA [Abstract]
Total revenues	$ 10,362	$ 8,588	$ 9,707	$ 9,531	$ 8,870	$ 6,652	$ 9,992	$ 7,869	$ 38,188	$ 33,383	$ 30,902
Gross profit	3,631	2,352	2,895	2,959	3,220	1,693	3,319	2,879	11,837	11,111	10,995
Operating income (loss)	595	(638)	(204)	(940)	214	(1,104)	664	231	(1,187)	5	1,236
Net income (loss)	$ 569	$ (668)	$ (227)	$ (967)	$ 220	$ (1,042)	$ 615	$ 220	$ (1,293)	$ 13	$ 1,160
Net income (loss) per share - basic and diluted (in dollars per share)	$ 0.04	$ (0.04)	$ (0.01)	$ (0.06)	$ 0.01	$ (0.07)	$ 0.04	$ 0.01
Weighted average shares-diluted (in shares)	16,029	15,994	15,929	15,868	15,575	15,462	16,062	15,926	15,949	15,838	15,564